Red cell mass measurement is still useful for myeloproliferative neoplasms management. Comment to “Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes Myeloprolifératifs”

Affiliations

Nada Maaziz: Pôle Biologie, CHU Dijon, France; Inserm U1231, Université de Bourgogne, Dijon
François Girodon: Pôle Biologie, CHU Dijon, France; Inserm U1231, Université de Bourgogne, Dijon, France; Member of France Intergroupe Myeloprolifératifs (FIM); Laboratoire d’Excellence GR-Ex

Abstract

Not available.

ISSN: 0390-6078 (Print); 1592-8721 (Online)
Publisher: Ferrata Storti Foundation
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.haematologica.org